R&D News | pharmaphorum

News

Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.

News

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.

News

Dr Melanie Ivarsson has been appointed head of the UK's new Health Data Research Service, as the BIA selects Prof Chris Molloy as its new CEO.

News

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

News

AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.

News

FDA wants to exert regulatory flexibility on cell and gene therapies in an effort to bring them to patients more quickly and efficiently.